Loading organizations...
Wilson's Bird Capital operates as a Tel Aviv-based venture capital firm, specializing in investments across early to late growth-stage technology companies. The firm employs a data-driven investment strategy to identify and back high-performing, revenue-generating Israeli startups. They seek out companies demonstrating strong adaptability and versatility, aiming to partner with what they term "outliers" in the tech ecosystem.
The firm was established in 2022, founded on the insight of identifying and supporting exceptional companies that consistently outperform their peers. This approach allows Wilson's Bird Capital to focus its resources on ventures poised for significant advancement, driven by a philosophy of partnering with dynamic and rare opportunities within the technological landscape.
Wilson's Bird Capital primarily serves promising technology companies, from their initial growth phases through more mature stages, concentrating their efforts within the Israeli market. Their long-term vision is to discover and empower a select group of companies that exhibit strong performance and adaptability, positioning themselves as a strategic partner to future industry leaders.
Wilson's Bird Capital has 2 tracked investments across 2 companies. The latest tracked deal is $15.0M Series A in Rhino Health in May 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2025 | Rhino Health | $15.0M Series A | Alexi Nazem | Fusion Fund, Frank Sica, Arkin Digital Health, Gaingels, LionBird, Qiming Venture Partners USA, TELUS Ventures |
| Jun 1, 2023 | Onebeat | $10.0M Series B | Magenta Venture Partners | NFX, AnD Ventures, Incapital Ventures, J Ventures, Surround Ventures |